Computational Insights into Ligand Selectivity of Estrogen Receptors from Pharmacophore Modeling.

about

Identification of old drugs as potential inhibitors of HIV-1 integrase - human LEDGF/p75 interaction via molecular docking.

P2860

Q42717295-C6C1F466-330A-46D8-8BDD-2E8D621DD928

P2860

Computational Insights into Ligand Selectivity of Estrogen Receptors from Pharmacophore Modeling.

Item

http://www.wikidata.org/entity/Q54485705

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Computational Insights into Li ...... s from Pharmacophore Modeling.

@en

Computational Insights into Li ...... s from Pharmacophore Modeling.

@nl

type

Item

label

Computational Insights into Li ...... s from Pharmacophore Modeling.

@en

Computational Insights into Li ...... s from Pharmacophore Modeling.

@nl

prefLabel

Computational Insights into Li ...... s from Pharmacophore Modeling.

@en

Computational Insights into Li ...... s from Pharmacophore Modeling.

@nl

P1476

Computational Insights into Li ...... rs from Pharmacophore Modeling

@en

P2093

Guixia Liu

http://www.w3.org/2001/XMLSchema#string

Jie Shen

http://www.w3.org/2001/XMLSchema#string

Jing Fang

http://www.w3.org/2001/XMLSchema#string

Yun Tang

http://www.w3.org/2001/XMLSchema#string

Zhejun Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor beta

Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes

Pharmacophore modeling and three-dimensional database searching for drug design using catalyst.

Triarylpyrazoles with basic side chains: development of pyrazole-based estrogen receptor antagonists.

Deconstructing estradiol: removal of B-ring generates compounds which are potent and subtype-selective estrogen receptor agonists.

Evaluation of an estrogen receptor-beta agonist in animal models of human disease.

Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.

Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.

P304

539-549

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MINF.201000170

http://www.w3.org/2001/XMLSchema#string

P433

6-7

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Feixiong Cheng

P577

2011-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27467155

http://www.w3.org/2001/XMLSchema#string

Computational Insights into Ligand Selectivity of Estrogen Receptors from Pharmacophore Modeling.

about

P2860

P2860

Computational Insights into Ligand Selectivity of Estrogen Receptors from Pharmacophore Modeling.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698